Zynerba Pharmaceuticals Announces Initiation of STAR 2 Open-Label Extension Clinical Trial for ZYN002 CBD Gel in Adult Refractory Epilepsy Patients
/
Date02 Nov 2016
DEVON, Pa., Nov. 02, 2016 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic... Read More →
AveXis Announces Single-Arm Design for U.S. Pivotal Study of AVXS-101 in SMA Type 1 Patients
/
Date01 Nov 2016
– Company provides update following receipt of FDA minutes from Type B meeting – – Conference call and webcast November 1 at 4:30 p.m. EDT –... Read More →
Tesaro Announces Submission of Niraparib New Drug Application for Platinum-Sensitive, Recurrent Ovarian Cancer
/
Date01 Nov 2016
WALTHAM, Mass., Nov. 01, 2016 (GLOBE NEWSWIRE) — TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced that it has completed the niraparib rolling New... Read More →
RedHill Biopharma to Host Investor Conference Call Today at 18:00 EDT Following Announcement of Proposed Public Offering of its American Depository Shares
/
Date01 Nov 2016
TEL-AVIV, Israel, Nov. 01, 2016 (GLOBE NEWSWIRE) — RedHill Biopharma Ltd. (NASDAQ:RDHL) (TASE:RDHL) (“RedHill” or the “Company”), a biopharmaceutical company primarily focused on the development... Read More →
Celldex Expands Antibody and Immuno-Oncology Portfolio with the Acquisition of Kolltan Pharmaceuticals
/
Date01 Nov 2016
HAMPTON, N.J., and NEW HAVEN, Conn., Nov. 01, 2016 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that the Company has entered into a... Read More →
Kessler Foundation Awarded $2.3 Million Spinal Cord Injury Model System Grant
/
Date01 Nov 2016
EAST HANOVER, N.J., Nov. 1, 2016 (GLOBE NEWSWIRE) — Kessler Foundation has been awarded a Spinal Cord Injury Model System (SCIMS) grant valued at $2,300,000... Read More →
Pluristem’s Pivotal Phase III Critical Limb Ischemia Trial Approved by UK Regulatory Agency
/
Date01 Nov 2016
Pluristem expects to begin patient enrollment in the UK in first half of 2017 The trial will recruit in the U.S. and EU HAIFA, Israel,... Read More →
Cempra Receives $10 Million Milestone Payment From Toyama Chemical (a Subsidiary of FUJIFILM Holdings Corporation) as Solithromycin Progresses to Phase 3 Studies in Japan
/
Date01 Nov 2016
CHAPEL HILL, N.C., Nov. 01, 2016 (GLOBE NEWSWIRE) — Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs... Read More →
Amaranth Medical Initiates Trial of Sub-100-Micron MAGNITUDE Sirolimus-Eluting Bioresorbable Scaffold
/
Date01 Nov 2016
MOUNTAIN VIEW, CA , Nov. 01, 2016 (GLOBE NEWSWIRE) — Amaranth Medical, a privately held medical device company, announced the initiation of a clinical study... Read More →
Chiasma Recognizes Acromegaly Awareness Day with New Resources for Patients and Data Presentation for Physicians
/
Date01 Nov 2016
Data from a Novel Patient-Reported Outcome Tool Assessing Acromegaly Treatment Satisfaction to be Presented Tools for Patients Added to Acromegaly.care WALTHAM, Mass., Nov. 01, 2016... Read More →